Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 16729-292

4 FDA label images from Accord Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 16729-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dalfa 01)

Chemical Structure (Dalfa 01)
Chemical structure of dalfampridine showing a pyridine ring with an amino group attached, representing the molecule's composition.*
FDA Label Image

Figure 1 (Dalfa 02)

Figure 1 (Dalfa 02)
A bar chart comparing the average percent increase in walking speed from baseline between patients taking Dalfampridine 10 mg twice daily and placebo. The x-axis shows different thresholds of walking speed improvement (≥0%, ≥10%, ≥20%, ≥30%, ≥40%, ≥50%, ≥60%), and the y-axis shows the percentage of patients achieving each threshold, with Dalfampridine consistently higher at lower thresholds.*
FDA Label Image

Figure 2 (Dalfa 03)

Figure 2 (Dalfa 03)
A bar graph comparing the average percent increase in walking speed from baseline between placebo and Dalfampridine 10mg b.i.d. groups. The x-axis shows different thresholds of walking speed increase (≥0%, ≥10%, ≥20%, etc.), and the y-axis shows the percentage of patients meeting each threshold. Bars for placebo and Dalfampridine groups are shown side-by-side with p-values indicated for comparisons.*
FDA Label Image

Principal Display Panel (10 mg Tablet carton)

Principal Display Panel (10 mg Tablet carton)
Label for Dalfampridine 10 mg extended-release tablets by Accord Healthcare Inc. The label includes dosing instructions, storage conditions, and safety warnings. The package size is 30 film-coated tablets, with a note to dispense a medication guide to each patient. Manufactured by Intas Pharmaceuticals Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.